Raloxifene Reverses Bone Loss in Postmenopausal Women with Mild Asymptomatic Primary Hyperparathyroidism

José Zanchetta(Universidad del Salvador), César E. Bogado(Universidad del Salvador)

Journal of Bone and Mineral Research

January 1, 2001

10.1359/jbmr.2001.16.1.189

Cited by 64

Related Papers

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

|New England Journal of Medicine|2001|4.6k

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

|New England Journal of Medicine|2009|3.5k

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

|New England Journal of Medicine|2014|1.2k

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial

|Journal of Bone and Mineral Research|2008|508

Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial

|Arthritis & Rheumatism|2009|497